CHANGCHUN, China and LOS ANGELES, Feb. 1 /PRNewswire-Asia/ -- China Yongxin Pharmaceutical, Inc. (OTC Bulletin Board: CYXN) (the Company), one of the fastest growing, vertically-integrated health products companies in China, today announced it has retained Strategic Growth International, Inc. ("SGI"), to perform certain U.S. and international investor relations functions to increase awareness of the Company in the investment community.
According to Mr. Yongxin Liu, the Company's Chairman and CEO, "We are very pleased that SGI has joined the Yongxin team. This takes place during an important period of corporate growth for Yongxin, as we continue the building out of our extensive product portfolio, expand our marketing activities, and substantially increase the source of our retail presence in China. As a rapidly growing health and wellness company, we want to be represented internationally by a major investor relations firm that is well known and respected by investors in leading growth-companies. SGI's expertise will help us to identify institutions internationally that recognize the value of the competitive advantage of our products and the added value of our extensive distribution and sales presence in China. We recognize SGI's global experience in leading healthcare companies like us. With the addition of SGI to our team, together with Rodman and Renshaw as our financial advisor, this will substantially enhance our position in the capital markets."
About China Yongxin Pharmaceuticals, Inc.
Founded in 1993, China Yongxin Pharmaceutical is a manufacturer, retailer and distributor of Chinese traditional medicines, pharmaceutical preparations, natural health products, health food, cosmetics, and medical equipment in Northeastern China. Its retail operations began in 2004, and in 2005, it gained franchise rights from one of the world's largest drug chains for China's Jilin Province. By the end of 2007, the Company had become one of the fastest growing drug retailers in China through its retail chain of 93 drug outlets as well as wholesale distribution and manufacturing operations in Northeastern China. For more information about China Yongxin Pharmaceuticals, please visit http://www.yongxinchina.com .
About Strategic Growth International, Inc.
Founded in 1989, SGI is headed by Stanley Altschuler and Richard Cooper, two long-time and highly respected Wall Street veterans, who have assembled an experienced team of investment/financial professionals to serve their clients. Since its inception in 1989, Strategic Growth has achieved an unparalleled success for over a hundred clients. Leading this account for SGI is Richard Cooper, Chairman and Linda Ni, Vice President.
Forward Looking Statements
This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. The forward-looking statements are also identified through the use of words "believe," enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict" "probable," "potential," "possible," "should," "continue," "project", "expect" and other words of similar meaning. Actual results could differ materially from these forward-looking statements as a result of a number of risk factors detailed in the Company's periodic reports filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. China Yongxin Pharmaceutical Inc. does not assume any duty to publicly update or revise the material contained herein.
For more information, please contact:
CORPORATE:
China Yongxin Pharmaceuticals, Inc.
Sam Liu, COO
Tel: +1-626-581-9098
Email: info@yongxinchina.com
INVESTOR RELATIONS:
Strategic Growth International, Inc.
Richard Cooper, or
Linda Ni
Tel: +1-212-838-1444
Email: rcooper@sgi-ir.com ; lni@sgi-ir.com